Contact Sypharma
Sypharma Pty Ltd.
27 Healey Road Dandenong,
VICTORIA 3175, AUSTRALIA
Enquiries Form
COVAX-19 vaccine reaches major milestone in the race for approval.
COVID-19 vaccine developed by Vaxine Pty Ltd is the first Australian vaccine to reach final Phase 2 and 3 clinical trials.
Read Case Study
COVID19 Pandemic Products – Hand Sanitisers and Disposable Masks.
As Sypharma continues to closely monitor the CoVID-19 Pandemic, our primary concern is the health and safety of our staff, customers and the community. We will continue to deliver our products and we will endeavor to maintain our supply chain at this critical time in order to minimize disruptions to our customers.
Read Case Study
Sypharma and Schott Unlocking Possibilities Together
Together SYPHARMA and SCHOTT offer value beyond superior quality. We develop products and services that
Read Case Study
not only deliver reliability and accuracy but improve our customers’ efficiency and performance.
Quality our clients rely on
University of Queensland partners with Sypharma
Sypharma partners with The University of Queensland for the manufacture of their CoVID-19 Vaccine Product.
Read Press Release
Technovalia, Sypharma and BioNet announce the establishment of Genetis
Technovalia, Sypharma and BioNet announce the establishment of Genetis, the first Australian Vaccine Development and Manufacturing Hub for mRNA, DNA and recombinant vaccines.
Read Press Release
Sypharma partners with Vaxine Pty Ltd. to manufacture COVID-19 vaccine.
Sypharma partners with Vaxine Pty Ltd. to manufacture COVID-19 vaccine product.
Read Press Release
Australian startups push for bigger role in vaccine-making.
Australian startups push for bigger role in vaccine-making.
Read Press Release
CoVax19 – Merck Vaxine Sypharma Press Release.
Sypharma Partners with Vaxine — COVAX-19 Vaccine Candidate Enters Phase 1 Human Trials.
Read Press Release
